IP Library Granted Patent US 11,752,186
Granted Patent B2
US 11,752,186 · App. 16/201,057 · Granted Sep 12, 2023

Maca compositions and methods of use

Inventors: James R. Komorowski (Trumbull, CT); Sara Perez Ojalvo (New York, NY)
Assignee: JDS Therapeutics, LLC
A61K36/31A23L2/00A61K9/00A61K9/0053A61K9/0095A61K9/1664
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,752,186
App. No.
16/201,057
Granted
Sep 12, 2023
Kind
B2
Abstract

The present application is directed to composition comprising various maca extracts and the use of such compositions for treating certain diseases, disorders, and conditions.

Claims (20)

1. A nutritional supplement comprising:

an effective amount of a maca composition ( Lepidium meyenii ), wherein the maca composition comprises a synergistic combination consisting essentially of black maca and red maca in a ratio of about 1:1;

wherein the maca composition has between about 15 and 40 grams of total sugar per 100 grams of the maca composition;

wherein the nutritional supplement is provided in a dosage form and the dosage form is selected from the group consisting of a tablet, a dispersible powder or granule, an emulsion, a hard capsule, a soft capsule, a non-gelatinous capsule, and a plant-derived capsule;

wherein the maca composition does not include yellow, purple, blue, and green maca phenotypes; and

wherein the synergistic combination, when administered to a subject in an effective amount, increases cellular energy in the subject.

2. The nutritional supplement of claim 1 , wherein the nutritional supplement further comprises an additive.

3. The nutritional supplement of claim 2 , wherein the additive is selected from the group consisting of palm oil, sunflower oil, soy lecithin, and glycerin.

4. The nutritional supplement of claim 1 , wherein the maca composition comprises polyphenols, proteins, amino acids or combinations thereof.

5. The nutritional supplement of claim 1 , wherein the effective amount of the maca composition is effective to decrease cytokine activity in a subject in need thereof.

6. A nutritional supplement comprising:

an effective amount of maca composition ( Lepidium meyenii ), wherein the maca composition comprises a synergistic combination consisting essentially of black maca and red maca in a ratio of about 4:1;

wherein the maca composition has between about 15 and 40 grams of total sugar per 100 grams of the maca composition;

wherein the nutritional supplement is provided in a dosage form and the dosage form is selected from the group consisting of a tablet, a dispersible powder or granule, an emulsion, a hard capsule, a soft capsule, a non-gelatinous capsule, and a plant-derived capsule;

wherein the maca composition does not include yellow, purple, blue, and green maca phenotypes; and

wherein the synergistic combination, when administered to a subject in an effective amount, decreases cytokine activity, wherein the cytokine is selected from the group consisting of IL-1β, IL-6, IL-8, IP-10, IL-4, IFN-γ, and combinations thereof.

7. The nutritional supplement of claim 6 , wherein the nutritional supplement further comprises an additive.

8. The nutritional supplement of claim 7 , wherein the additive is selected from the group consisting of palm oil, sunflower oil, soy lecithin, and glycerin.

9. The nutritional supplement of claim 6 , wherein the maca composition comprises polyphenols, proteins, amino acids or combinations thereof.

10. The nutritional supplement of claim 6 , wherein the effective amount of the maca composition is effective to decrease cytokine activity in a subject in need thereof.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 29, 2023
From: JDS THERAPEUTICS, LLC
To: BONAFIDE HEALTH, LLC
Reel/Frame 065072/0787 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 9, 2021
From: NUTRITION 21, LLC
To: JDS THERAPEUTICS, LLC
Reel/Frame 056808/0601 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 27, 2018
From: KOMOROWSKI, JAMES R.; OJALVO, SARA PEREZ
To: JDS THERAPEUTICS, LLC
Reel/Frame 047591/0846 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 27, 2018
From: JDS THERAPEUTICS, LLC
To: NUTRITION 21, LLC
Reel/Frame 047591/0871 →